Physician profile
Robert Ochoa
NPI 1295987139
$14,816.74
in general payments reported to CMS, 2019-2025
13 companies · $1.99 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.65 · 2020: $6,065 · 2021: $6,530 · 2022: $2,051 · 2023: $134 · 2024: $6.14 · 2025: $1.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,788.07 | 2020-2022 | |
| Merz North America, INC. | $504.69 | 2021 | |
| Edwards Lifesciences Corporation | $203.68 | 2022 | |
| Tela Bio, INC. | $92.21 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $58.00 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Vapotherm INC | $34.97 | 2022 | |
| Eisai INC. | $25.64 | 2021 | |
| Boston Scientific Corporation | $24.95 | 2022 | |
| Merck Sharp & Dohme LLC | $23.45 | 2020 | |
| Ethicon US, LLC | $16.65 | 2019 | |
| Integra Lifesciences Corporation | $15.76 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Convatec INC. | $14.79 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ochoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.